What question did this study set out to answer?

To present version 13 of the augmanitai stage-0 corpus and its enhancements.

May 13, 2026Open Access

AUGMANITAI Stage-0 V13 - 33422 Terms (Restricted, Final-Wave-After-V12, 2026-05-11)

Puntos clave

To present version 13 of the augmanitai stage-0 corpus and its enhancements.
Analysis of additional terms incorporated into the corpus
Implementation of various filters during pre-publishing
Validation checks for data integrity and reliability
Inclusion of 176 additional pages to the corpus
Achieved a 100% pass rate for pre-publish validation checks
Enhanced filtering for specific content types and concerns

Resumen

AUGMANITAI Stage-0 V13 - 33422 Phenomenological Terms (Research Preprint, Restricted, Final-Wave-After-V12, 2026-05-11). This is V13 of the AUGMANITAI Stage-0 corpus. Concept-DOI 10. 5281/zenodo. 20118267 (persistent). Delta: 176 additional pages from final pool-sweep. Atlas 33258 to 33423. 100% Gate-v4 + Pre-Publish-Gate pass-rate on full corpus. Pre-Publish Gate (extended v4): 47 base checks + Children-Mentions filter, Violence (physical/psychological) filter, Instruction/Imperative filter, Du-Ansprache filter. Body-text analysis excludes Disclaimer/Footer/Verantwortlich sections (legitimately contain §14 'you' references). Single Source of Truth: canonicalᵢds. json. Backend Andy-Legend in every Schema. org Person-block. Multi-Hash: SHA-256 dab7f089a9c0a88bed565821cecb642a3a1adc3aa9f991251e04964d96b20b45 - SHA-512 d903f4bbcdb3f6aaa319adb22876cd46. . . - SHA3-256 0e2ee3bd6b59a544ee077d4c312dcf158992d84750a89fb1bdbba86cd866cf5c - BLAKE3 3baa6b633a63a63d3455859c531636d28b02c1c91ccbd8c8d79b28b72632a4ac. Access: RESTRICTED. Verantwortlich i. S. d. § 5 DDG / § 18 Abs. 2 MStV: Andreas Ehstand, Nepomukweg 7, 82319 Starnberg, Deutschland. Kontakt: augmanitai@gmail. com. Aufsicht DSGVO: Bayerisches Landesamt für Datenschutzaufsicht, Promenade 18, 91522 Ansbach.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Andreas Ehstand (Mon,) studied this question.

www.synapsesocial.com/papers/6a03cbfc1c527af8f1ecfc37 — DOI: https://doi.org/10.5281/zenodo.20126969

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AUGMANITAI Stage-0 V13 - 33422 Terms (Restricted, Final-Wave-After-V12, 2026-05-11)

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Actions

References and Citations

Citation Network

Connected Papers

Discussion